About
Interstitial Lung Disease Treatment
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
89
By Phase
PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05983471Lead Sponsor
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
PHASE2Active, not recruiting
40 participants
Started: Apr 1, 2024 · Completed: Sep 30, 2025
NCT05925920Lead Sponsor
Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
PHASE1Active, not recruiting
49 participants
Started: Jun 13, 2023 · Completed: Dec 6, 2024
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...